相关实验视频

Updated: Jan 17, 2026

Isolating Human Peripheral Blood Mononuclear Cells and CD4+ T cells from Sézary Syndrome Patients for Transcriptomic Profiling

Isolating Human Peripheral Blood Mononuclear Cells and CD4+ T cells from Sézary Syndrome Patients for Transcriptomic Profiling

Published on: October 14, 2021

SOCS3:一种免疫学生物标志物,为恶性瘤提供潜在的治疗标

Yan Zhang¹, Meiling Chu², Meina Ye¹

¹Department of Breast Surgery, Longhua Hospital, Shanghai University of Traditional Chinese Medicine, 725 South Wanping Road, Shanghai, 200032, China.

Biological procedures online

|September 22, 2025

概括

细胞因子信号传递3抑制剂 (SOCS3) 调节细胞因子信号传递并影响癌症. 异常的SOCS3表达驱动瘤生长,使其成为新型癌症治疗的潜在目标.

科学领域:

在瘤学瘤学.
分子生物学分子生物学
免疫学免疫学免疫学

背景情况:

细胞因子信号传递3抑制剂 (SOCS3) 是简氏激酶 (JAK) /信号转换器和转录激活器 (STAT) 途径的关键调节者.
异常的SOCS3表达与各种恶性瘤的发展和进展有关.
失调的SOCS3会影响癌细胞的生长,迁移和亡.

研究的目的:

提供SOCS3在癌症中的作用的全面概述.
探索SOCS3的分子结构,生物功能和瘤中的机制.
讨论针对SOCS3进行癌症治疗的治疗策略.

主要方法:

关于SOCS3在癌症中的研究的文献综述.
对SOCS3参与细胞因子和激素信号通路的分析.
关于SOCS3的诊断,预后和治疗潜力的信息综合.

主要成果:

SOCS3对于调节细胞因子信号传递至关重要,并影响瘤进展.
异常的SOCS3表达与癌症中不受控制的细胞增殖和生存相关.
在瘤学中,SOCS3具有作为生物标志物和治疗点的潜力.

结论:

SOCS3在癌症的发展和进展中起着重要作用.
准SOCS3为创新的癌症治疗提供了有前途的途径.
对SOCS3机制的进一步研究可以提高其在瘤学中的临床实用性.

关键词:

免疫性微环境免疫性微环境免疫信号传递免疫信号传递免疫系统的目标是免疫系统.免疫治疗是一种免疫疗法.恶性瘤恶性瘤抑制细胞因子信号传递3的抑制剂治疗目标治疗目标

更多相关视频

Quantifying Antibody-Dependent Cellular Cytotoxicity in a Tumor Spheroid Model: Application for Drug Discovery

Quantifying Antibody-Dependent Cellular Cytotoxicity in a Tumor Spheroid Model: Application for Drug Discovery

Published on: April 26, 2024

Three-Dimensional 3D Tumor Spheroid Invasion Assay

Three-Dimensional 3D Tumor Spheroid Invasion Assay

Published on: May 1, 2015

相关概念视频

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

The Tumor Microenvironment

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...